$RFP

Resolute Forest Products Inc

  • NEW YORK STOCK EXCHANGE INC.
  • Process Industries
  • Pulp & Paper
  • Manufacturing
  • Pulp Mills

PRICE

$20.54 -

Extented Hours

VOLUME

366,932

DAY RANGE

20.43 - 20.53

52 WEEK

9.84 - 20.73

Join Discuss about RFP with like-minded investors

profile
@dros #droscrew
recently

RECAP 7/6 Unusual Calls: $RFP Jul 20 C $LCID Jul 18/19.5 C $NKLA Jul 5.5/6 C $TLRY Jul08 3.5 C $OPEN Jan 12.5 C $SNAP Jul15/22 17 C $CLF Jan 25 C $GERN Jan 4 C $ELAN Sep 21 C $TECK Aug 30 C $BLND Nov 2.5/5 C $DKNG Jul 13.5 C $TWTR Jun2023 52.5 C $IAU Oct 35 C $NVDA Oct 190 C

91 Replies 7 👍 14 🔥

profile
@CarlosH-carvan #ivtrades
recently

$RFP nice buyout.....OI great

127 Replies 6 👍 15 🔥

profile
@dros #droscrew
recently

RECAP 7/5 Unusual Calls: $BAC Jan-24 42/50 C Spd $RBLX Jul 39 C $AMZN Jul 120 C $AAL Jan 19 C $BCS Sep 8 C $PINS Jul22 20 C $TSLA Aug 1000 C $BECN Oct 50 C $FTI Aug 8 C $AMZN Sep 175 C $RFP Jul 15 C $LCID Jul 18 C $NLOK Aug 25 C $CLVS Jul 3 C $VTI Jan 220 C

57 Replies 10 👍 12 🔥

profile
@dros #droscrew
recently

RECAP 6/15 Unusual Calls: $AR Jul 41 C $ICLN Jul 20 C $DAL Aug 41 C $META Jan2024 420 C $CRC Dec 60 C $DKNG Jun24 15.5 C $KO Sep 70 C $HYG 76.5 C $RFP Jul 20 C $AGNC Jan 13 $PYPL Jul 95 C

65 Replies 6 👍 9 🔥

profile
@lucullus #droscrew
recently

i used to trade with $RFP but it was to frustrating...number of options turned to nothing in that thing been huge

57 Replies 8 👍 11 🔥

profile
@dros #droscrew
recently

5000 $RFP JUL2022 $20 Cs trade 0.3

132 Replies 12 👍 9 🔥

profile
@dros #droscrew
recently

5000 $RFP JUL2022 $20 Cs trade 0.3

113 Replies 11 👍 12 🔥

profile
@viking #StockTraders.NET
recently

Upside: -NOVN +32% (reports positive topline results from pivotal Phase III trial of SB206 in patients with molluscum contagiosum) -PGEN +28% (announces positive topline results from Phase 1b/2a study of AG019 ActoBiotics, a Novel Therapy designed to address the underlying cause of Type 1 Diabetes; primary endpoints were met) -GENE +15% (US Patent Office grants foundational pharmacogenomic patent) -MX +15% (confirms 21% improved rival bid of $35/shr cash unsolicited proposal from Cornucopia Investment Partners) -ZDGE +9.5% (earnings, guidance) -ATC +8.4% (MKS Instruments said to have approached Atotech for acquisition) -ADMP +5.9% (provides update on clinical trial start-up progress for tempol in the treatment of COVID-19) -RFP +5.6% (announces $1/share Special Dividend, and $50M in lumber investments) -PLAY +5.3% (earnings, guidance) -AUTL +5.1% (presents new data on obe-cel in r/r Indolent B cell lymphomas and gives an update of obe-cel in r/r Adult ALL at the European Hematology Association Virtual Congress) -MBIO +5.0% (announced updated interim Phase 1/2 data for MB-106) -TYME +5.0% (comprehensive strategic review identified breast cancer as a priority indication for development, a focus on second-line pancreatic cancer, and continuation of trial in high-risk sarcomas) -LIFE +2.5% (presents poster demonstrating functional selectivity of second Anti-NRP2 Antibody) -OCGN +1.4% (Roth Capital broker downgrade) -AVO +1.3% (earnings, guidance) Downside: -ORPH -52% (application for MIPLYFFA under priority review with FDA, expected Prescription Drug User Fee Act action date of June 17; company not aware for reason for stock volatility) -VRTX -14% (reports primary endpoint achieved in Phase 2 Study of VX-864 in Alpha-1 Antitrypsin Deficiency but magnitude of treatment effect observed unlikely to translate into substantial clinical benefit) -CVAC -11% (downside momentum) -INCY -4.0% (FDA extendes the New Drug Application review period for ruxolitinib cream for the treatment of atopic dermatitis) -ADC -3.9% (prices 4.0M shares at implied $71.50/shr to raise $286M) -SNOW -3.7% (provides 2029 financial targets) -ELY -3.6% (to join S&P MidCap 400) -LTHM -3.2% (prices 13M shares at $17.50/shr) -AGNC -3.1% (reports tangible net book value) -RCL -2.1% (two guests aboard Celebrity Millennium test positive for COVID during required end-of-cruise testing) -CHWY -1.4% (earnings, guidance)

40 Replies 7 👍 13 🔥

Key Metrics

Market Cap

1.57 B

Beta

1.17

Avg. Volume

0.97 M

Shares Outstanding

76.80 M

Yield

0%

Public Float

0

Next Earnings Date

2022-11-03

Next Dividend Date

Company Information

Resolute Forest Products is a global leader in the forest products industry with a diverse range of products, including market pulp, tissue, wood products and papers, which are marketed in over 50 countries. The company owns or operates some 40 facilities, as well as power generation assets, in the United Statesand Canada. Resolute has third-party certified 100% of its managed woodlands to internationally recognized sustainable forest management standards.

CEO: Arnold Nemirow

Website:

HQ: 55 E Camperdown Way Greenville, 29601-3511 South Carolina

Related News